Notice of Meeting, 34857-34858 [2023-11498]
Download as PDF
Federal Register / Vol. 88, No. 104 / Wednesday, May 31, 2023 / Notices
FEDERAL RESERVE SYSTEM
GENERAL SERVICES
ADMINISTRATION
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
[Notice–MA–2023–06; Docket No. 2023–
0006; Sequence No. 01]
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than June 29, 2023.
lotter on DSK11XQN23PROD with NOTICES1
A. Federal Reserve Bank of
Minneapolis (Stephanie Weber,
Assistant Vice President)
90 Hennepin Avenue, Minneapolis,
Minnesota 55480–0291. Comments can
also be sent electronically to MA@
mpls.frb.org:
1. Heritage Bancshares Group Inc.
Employee Stock Ownership Plan and
Trust, Spicer, Minnesota; to acquire up
to 41.12 percent of the voting shares of
Heritage Bancshares Group, Inc., and
thereby indirectly acquire voting shares
of Heritage Bank, N.A., both of Spicer,
Minnesota.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–11440 Filed 5–30–23; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:50 May 30, 2023
Jkt 259001
Federal Travel Regulation (FTR);
Agency Reporting Requirements
Office of Government-wide
Policy (OGP), General Services
Administration (GSA).
ACTION: Notice of GSA Bulletin FTR 23–
06, travel reporting information profile
(trip) reporting requirements.
AGENCY:
GSA Bulletin FTR 23–06
announces updates to the reporting
requirements for annual travel and
transportation information, commonly
called the TRIP report.
DATES: Applicable: May 31, 2023.
FOR FURTHER INFORMATION CONTACT: For
clarification of content, contact LaMan
Dantzler J.D., Office of Governmentwide Policy, Office of Asset and
Transportation Management, at
travelpolicy@gsa.gov, or 202–615–5399.
Please cite Notice of GSA Bulletin FTR
23–06.
SUPPLEMENTARY INFORMATION: 5 United
States Code 5707(c), as implemented in
Federal Travel Regulation (FTR) Part
300–70, directs agencies (as defined in
FTR § 301–1.1) to report specific
information on payments for temporary
duty travel and employee relocation no
later than November 30 of each year to
the General Services Administration
(GSA). The head of the agency is
responsible for ensuring the reported
information is complete and accurate, to
include information from all
components of the agency, before
submitting it to GSA (FTR 300–70.3;
300–70.4).
Executive Order 14057, ‘‘Catalyzing
Clean Energy Industries and Jobs
Through Federal Sustainability’’ and its
implementing instructions direct GSA
to establish tracking and provide annual
reporting of agency-specific and
Government-wide Scope 3 greenhouse
gas (GHG) carbon emissions for
employee travel.
The E-Gov Travel Service (ETS) and
the Department of Defense’s Defense
Travel System (DTS) and MyTravel
solutions capture mileage information
required to compute a carbon footprint
for commercial airline and privately
owned vehicle travel, but GSA cannot
extract this mileage data directly from
other agencies’ travel solutions. To
consolidate travel-related information
into a single repository while enabling
necessary GHG calculations, GSA is
adding mileage components to the
information agencies must submit in the
TRIP report.
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
34857
GSA Bulletin FTR 23–06 can be
viewed in its entirety at https://
www.gsa.gov/ftrbulletins.
Saul A. Japson,
Principal Deputy Associate Administrator,
Office of Government-wide Policy.
[FR Doc. 2023–11436 Filed 5–30–23; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘Supporting the
Management of Substance Use Disorders
in Primary Care and other Ambulatory
Settings (R18)’’. This SEP meeting will
be closed to the public.
DATES: July 13, 2023.
ADDRESSES: Agency for Healthcare
Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20857.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20857, Telephone:
(301) 427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by AHRQ, and agree to
be available, to conduct on an as needed
basis, scientific reviews of applications
for AHRQ support. Individual members
of the Panel do not attend regularly
scheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4),
and 5 U.S.C. 552b(c)(6). Grant
applications for ‘‘Supporting the
Management of Substance Use Disorders
in Primary Care and other Ambulatory
Settings (R18)’’ are to be reviewed and
discussed at this meeting. The grant
applications and the discussions could
disclose confidential trade secrets or
SUMMARY:
E:\FR\FM\31MYN1.SGM
31MYN1
34858
Federal Register / Vol. 88, No. 104 / Wednesday, May 31, 2023 / Notices
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: May 24, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–11498 Filed 5–30–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Refugee Cash and Medical
Assistance Federal Financial Report
ORR–2 Supplemental Data Collection
(OMB #: 0970–0510)
Office of Refugee Resettlement,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
Refugee Resettlement (ORR) plans to
submit a generic information collection
(GenIC) request under the following
umbrella generic: Generic Clearance for
Financial Reports used for ACF
Mandatory Grant Programs (0970–0510).
SUMMARY:
This request is to include instructions
for ORR Refugee Cash and Medical
Assistance (CMA) grant recipients to
provide supplemental financial
information when submitting the
already required ORR–2 Financial
Report, which is approved under Office
of Management and Budget (OMB)
number 0970–0407.
DATES: Comments due within 14 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above and below.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: ACF programs require
detailed financial information from their
grantees that allows ACF to monitor
various specialized cost categories
within each program to closely manage
program activities and to have sufficient
financial information to enable periodic
thorough and detailed audits. The
Generic Clearance for Financial Reports
used for ACF Mandatory Grant
Programs allows ACF programs to
efficiently develop and receive approval
for financial reports that are tailored to
specific funding recipients and the
associated needs of the program. For
more information about the umbrella
generic, see: https://www.reginfo.gov/
public/do/PRAViewICR?ref_
nbr=202303-0970-002.
This specific GenIC request applies to
all ORR Refugee Cash and Medical
Assistance grantees awarded traditional
base funding as well as funding received
under the Afghanistan Supplemental
Appropriations Act, 2022 (ASA), and
the Ukraine Supplemental
Appropriations Act, 2022, and other
appropriations as communicated. All
grantees must complete reporting in
accordance with statute. Currently,
grantees use the ORR–2 (OMB #: 0970–
0407) to report federal expenditures by
program categories such as refugee cash
assistance and refugee medical
assistance. The ORR–2 requests grantees
to report on the various program
categories totaling expenditures,
unliquidated obligations, and
unobligated balances. ORR is proposing
to request that grantees break out
unobligated balances reported on the
final ORR–2 financial report by funding
source (base, ASA, Ukraine) and
financial account number as referenced
on the Notice of Award as a Word or
Excel attachment to upload (with the
ORR–2 report) in the Online Line Data
Collection via the designated link. This
final report is due September 30th. The
proposed supplemental instructions
will provide guidance and assist
grantees with submitting the additional
detail about Federal expenditure data
reported on the ORR–2. The analysis of
this data would further support
adherence to program requirements.
Respondents: States, State Agency
Grantee Designees.
lotter on DSK11XQN23PROD with NOTICES1
ANNUAL BURDEN ESTIMATES
Title of information collection
Number of
respondents
Annual
frequency
of responses
Hourly
burden per
response
Annual
hourly burden
RSS SF–425 Supplemental Data Collection ...................................................
66
1
1.67
110
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
VerDate Sep<11>2014
16:50 May 30, 2023
Jkt 259001
to comments and suggestions submitted
within 14 days of this publication.
Authority: Section 412(c)(1)(A) of the
Immigration and Nationality Act (8
U.S.C. 1522(c)(1)(A)).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Mary B. Jones,
ACF/OPRE Certifying Officer.
Submission for Office of Management
and Budget (OMB) Review; Monitoring
and Compliance for ORR Care Provider
Facilities (OMB #: 0970–0564)
[FR Doc. 2023–11479 Filed 5–30–23; 8:45 am]
BILLING CODE 4184–89–P
PO 00000
Administration for Children and
Families
Office of Refugee Resettlement,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
AGENCY:
ACTION:
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\31MYN1.SGM
Request for public comments.
31MYN1
Agencies
[Federal Register Volume 88, Number 104 (Wednesday, May 31, 2023)]
[Notices]
[Pages 34857-34858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11498]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ)
announces a Special Emphasis Panel (SEP) meeting on ``Supporting the
Management of Substance Use Disorders in Primary Care and other
Ambulatory Settings (R18)''. This SEP meeting will be closed to the
public.
DATES: July 13, 2023.
ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600
Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427-1557.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
AHRQ, and agree to be available, to conduct on an as needed basis,
scientific reviews of applications for AHRQ support. Individual members
of the Panel do not attend regularly scheduled meetings and do not
serve for fixed terms or a long period of time. Rather, they are asked
to participate in particular review meetings which require their type
of expertise.
The SEP meeting referenced above will be closed to the public in
accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for
``Supporting the Management of Substance Use Disorders in Primary Care
and other Ambulatory Settings (R18)'' are to be reviewed and discussed
at this meeting. The grant applications and the discussions could
disclose confidential trade secrets or
[[Page 34858]]
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: May 24, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-11498 Filed 5-30-23; 8:45 am]
BILLING CODE 4160-90-P